Oncomatryx Biopharma S.l.
Clinical trials sponsored by Oncomatryx Biopharma S.l., explained in plain language.
-
New weapon against tough cancers enters human testing
Disease control Recruiting nowThis is a first-in-human study to find a safe dose of a new experimental drug called OMTX705 for patients with advanced solid tumors that have stopped responding to standard treatments. The trial will test OMTX705 by itself and combined with existing immunotherapy drugs. The main…
Phase: PHASE1 • Sponsor: Oncomatryx Biopharma S.L. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New weapon tested in fight against tough pancreatic cancer
Disease control Recruiting nowThis early-stage trial is testing a new drug called OMTX705, given alongside standard chemotherapy and an immunotherapy drug, for people with advanced pancreatic cancer that has spread. The main goal is to find a safe dose and see how well the body tolerates the combination. Rese…
Phase: PHASE1 • Sponsor: Oncomatryx Biopharma S.L. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC